Eximis Surgical Inc., develops innovative technologies for the removal of large specimens during minimally invasive procedures. The company is in the pre-market phase and is actively working towards FDA submission for its first device in the platform. Eximis Surgical’ proprietary technology is designed to provide surgeons a fully automated and contained system that leverages controlled RF energy delivery to segment large tissue specimens for removal through a small incision.